Business
Launch of Sensipod - First Point of Care Test
Launch of Sensipod - First Point of Care Test.
About this update from Avacta Group Plc
[{"type":"text","content":"\n \nRNS Number : 9171O Avacta Group PLC 26 September 2013 \n \n\n26 September 2013\nAvacta Group plc\n(\"Avacta\")\n \nLaunch of the Sensipod in-clinic blood testing system for vets\nFirst point of care test to provide a canine environmental allergy pre-screen\n \nAvacta Group plc (AIM: AVCT), a provider of diagnostic tools, consumables and reagents used in human and animal healthcare, announces that it has launched its in-clinic blood analysis system, Sensipod, to veterinary practices in the UK along with the first point of care test to screen dogs for environmental allergies.\n \nSensipod is an in-clinic diagnostic system designed to detect a wide range of markers of disease by rapidly carrying out an enzyme linked immunosorbent assay (ELISA) test - the gold standard for diagnostic tests - on a small sample of blood. The system is being launched in the UK with its first test, a canine environmental allergy pre-screen that assists the veterinarian in identifying allergies in dogs. Avacta is currently developing a large panel of additional tests for Sensipod covering common diseases in dogs, cats and horses, as well as other novel tests, which will provide a unique bench-top diagnostic capability for the veterinarian.\n \nAt the heart of the Sensipod system is an innovative single use cartridge, pre-loaded with test specific reagents, and the Sensipod bench-top instrument. The single use cartridge is capable of carrying out all of the steps of an ELISA test without any additional user interaction and provides a sensitive measure of disease biomarkers. When the full panel of tests is complete the Sensipod will equip vets with a state-of-the-art device that will provide a quick and easy diagnosis of some of the most common companion animal diseases.\n \nThe Sensipod in-clinic system complements Avacta's established reference laboratory diagnostic services which it provides to veterinarians in the UK, and its diagnostic test kits which it provides to third party reference laboratories globally. The programme of expansion of the Sensipod test menu will also generate new laboratory tests and diagnostic kits to expand the existing offering in these routes to market.\n \nAlastair Smith, Chief Executive of Avacta Group said: \n\"I am absolutely delighted that Sensipod has now launched and is in ...